In addition to the terms defined in 53-24-103, MCA, the following definitions shall apply in the interpretation and enforcement of the rules in this subchapter:
(1) "Administrator" means the person in charge, care, or control of treatment and responsible for operation of the agency providing such services.
(2) "Admission" means specific tasks necessary to admit a person to community-based substance use disorder treatment services. Tasks include but are not limited to:
(a) completion of admission forms;
(b) notification of client rights and confidentiality regulations;
(c) explanation of the general nature and goals of services;
(d) review of the intake policies and procedures of the service program;
(e) orientation to the service structure; and
(f) financial determination for services.
(3) "Adult" means a person 21 years of age or older for purposes of services in community-based substance use disorder inpatient and residential halfway house treatment.
(4) "American Society of Addiction Medicine Patient Placement Criteria 2R (ASAM PPC-2R) or (ASAM)" establishes the level of care for substance use disorder treatment and is required to be used by all licensed community-based substance use disorder inpatient and residential halfway house treatment facility providers. The department adopts and incorporates by reference the American Society of Addiction Medicine Patient Placement Criteria, Second Edition-Revised; Copyright 2001 by the American Society of Addiction Medicine, Inc.; ISBN 1-880425-06-8, which sets forth the level of care for substance use disorder treatment. A copy of ASAM PPC-2R may be obtained from American Society of Addiction Medicine, 4601 N. Park Avenue, Upper Arcade #101, Chevy Chase, MD 20815; phone (301) 656-3920; fax (301) 656 3815; or email@example.com.
(5) "Biopsychosocial assessment" means an assessment of a person's medical (biological), psychological, and social history based on the six dimensions of ASAM. The six assessment dimensions include:
(a) acute intoxication and/or withdrawal potential;
(b) biomedical conditions and complications;
(c) emotional, behavioral, or cognitive conditions and complications;
(d) readiness to change;
(e) relapse, continued use or continued problem potential; and
(f) recovery/living environment.
(6) "Child or adolescent" means a person under 21 years of age for purposes of services in community-based substance use disorder inpatient and residential halfway house treatment.
(7) "Client" means a person being treated for a substance use disorder who is formally admitted to services within the admission criteria set by the program.
(8) "Confidentiality" means a program requirement concerning client information, including client records. The disclosure of any information related to an individual client shall be governed by requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and the requirements of Title 42 Part 2.22 (a)(1) and (2) of the Code of Federal Regulations (CFR).
(9) "Continuing care plan" means a written plan outlining anticipated therapeutic interventions to move a client along the continuum of care, which may include the level of treatment, clinical needs, and rationale for moving from one level of care to another.
(10) "Co-occurring" means an individual has at least one mental disorder and a substance use disorder.
(11) "Detoxification (detox)" means care and treatment of a person while the person recovers from the transitory effects of acute or chronic intoxication or withdrawal from alcohol or other drugs.
(12) "Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or (DSM)" establishes criteria for diagnosing an individual with a substance use or dependence disorder and is published by the American Psychiatric Association. The department adopts and incorporates by reference the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Fourth Edition, (ISBN 0-89042-061-0 (hardback) or ISBN 0-89042-062-9 (paperback), which sets forth criteria for diagnosing an individual with a substance use or dependence disorder. A copy of the DSM-IV may be obtained from American Psychiatric Publishing, Inc., 1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209; phone (703) 907-7322 or (800) 368-5777; fax (703) 907-1091; or e-mail firstname.lastname@example.org.
(13) "Dual diagnosis capable (DDC)" means treatment programs address co-occurring mental and substance-related disorders in their policies and procedures, assessment, treatment planning, program content, and discharge planning are described as "dual diagnosis capable". Such programs have arrangements in place for coordination and collaboration with mental health services. They also can provide psychopharmacologic monitoring and psychological assessment and consultation, either on-site or through coordination consultation with off-site providers. Program staff is able to address the interaction between mental and substance-related disorders and their effect on the patient's readiness to change, as well as relapse and recovery environment issues, through individual and group content. Nevertheless, the primary focus of DDC programs is the treatment of substance-related disorders.
(14) "Dual diagnosis enhanced (DDE)" describes treatment programs that incorporate policies, procedures, assessments, treatment, and discharge planning processes that accommodate patients who have co-occurring mental and substance-related disorders. Mental health symptom management groups are incorporated into addiction treatment. Motivational enhancement therapies specifically designed for those with co-occurring mental and substance-related disorders are more likely available (particularly in outpatient settings) and, ideally, there is close collaboration or integration with a mental health program that provides crises back-up services and access to mental health case management and continuing care. In contrast to dual diagnosis capable services, dual diagnosis enhanced services place their primary focus on the integration of services for mental and substance-related disorders in their staffing, services, and program content.
(15) "Eligible licensed addiction counselor (ELAC)" means an individual who meets requirements set forth in 37-35-202, MCA, and ARM 24.154.407 to provide addiction counseling services under supervision of a licensed addiction counselor. References in this subchapter to licensed addiction counselor or LAC include an eligible licensed addiction counselor or ELAC providing addiction counseling services within the scope of this supervision.
(16) "First aid" means emergency treatment by someone who has received appropriate training. The provider and all staff who provide or supervise client care must complete required training and hold current certification in first aid and cardiopulmonary resuscitation (CPR).
(17) "Halfway house" means a community residential facility for treatment of substance use disorders.
(18) "Licensed addiction counselor (LAC)" means an individual who meets the requirements set forth in 37-35-202, MCA, and ARM Title 24, chapter 154, rules implementing 37-35-202, MCA, to provide addiction counseling.
(19) "Licensure bureau" means the area of the department responsible for licensing chemical dependency facilities.
(20) "Medication administration" means the direct application of a medication or device by ingestion, inhalation, injection, or any other means, whether self-administered by a resident, or administered by a parent or guardian (for a minor), or an authorized health care provider.
(21) "Parent" means the individual who has legal custody of the child.
(22) "Program" means a community-based substance use disorder inpatient and residential facility.
(23) "Treatment plan" means a written document identifying the clinical needs, goals, objectives, and interventions the client agrees to follow to help the client understand and meet these treatment objectives.
History: 50-5-103, 53-24-208, 53-24-301, MCA; IMP, 50-5-101, 50-5-103, 53-24-208, 76-2-411, MCA; NEW, 2010 MAR p. 2975, Eff. 12/24/10.